Resultados de la búsqueda

Santos-Beneit G, Bodega P, de Miguel M, Rodríguez C, Carral V, Orrit X, Haro D, Carvajal I, de Cos-Gandoy A, Peñalvo JL, Gómez-Pardo E, Oliva B, Ibañez B, Fernández-Alvira JM, Fernández-Jiménez R, Fuster V. Rationale and design of the SI! Program for health promotion in elementary students aged 6 to 11 years: A cluster randomized trial. Am Heart J (2019) 210:9-17
Link to the full text in Repisalud
Fernandez-Jimenez R, Santos-Beneit G, Tresserra-Rimbau A, Bodega P, de Miguel M, de Cos-Gandoy A, Rodriguez C, Carral V, Orrit X, Haro D, Carvajal I, Ibanez B, Storniolo C, Domenech M, Estruch R, Fernandez-Alvira JM, Lamuela-Raventos RM, Fuster V. Rationale and design of the school-based SI! Program to face obesity and promote health among Spanish adolescents: A cluster-randomized controlled trial. Am Heart J (2019) 215:27-40
Link to the full text in Repisalud
Toran JL, Lopez JA, Gomes-Alves P, Aguilar S, Torroja C, Trevisan-Herraz M, Moscoso I, Sebastiao MJ, Serra M, Brito C, Cruz FM, Sepulveda JC, Abad JL, Galan-Arriola C, Ibanez B, Martinez F, Fernandez ME, Fernandez-Aviles F, Palacios I, L RB, Vazquez J, Alves PM, Bernad A. Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization. Sci Rep (2019) 9:4647
Link to the full text in Repisalud
Rossello X, Rodriguez-Sinovas A, Vilahur G, Crisostomo V, Jorge I, Zaragoza C, Zamorano JL, Bermejo J, Ordonez A, Bosca L, Vazquez J, Badimon L, Sanchez-Margallo FM, Fernandez-Aviles F, Garcia-Dorado D, Ibanez B CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions Sci Rep (2019) 9:20290
Link to the full text in Repisalud
Zak MM, Gkontra P, Clemente C, Squadrito ML, Ferrarini A, Mota RA, Oliver E, Rocha S, Aguero J, Vazquez J, De Palma M, Ibanez B, Arroyo AG. Sequential bone marrow-cell delivery of VEGFA/S1P improves vascularization and limits adverse cardiac remodeling after myocardial infarction in mice. Hum Gene Ther (2019) 30:839-905
Link to the full text in Repisalud
Rodriguez-Serrano M, Rueda J, Buendía F, Monto F, Aguero J, Osa A, Cano O, Martínez-Dolz L, D’Ocon P. β2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation. Front Pharmacol (2019) 10:93
Link to the full text in Repisalud
Rossello X, Ferreira JP, McMurray JJ, Aguilar D, Pfeffer MA, Pitt B, Dickstein K, Girerd N, Rossignol P, Zannad F. Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction. Eur Heart J Acute Cardiovasc Care (2019) 8:231-41
Rossello X, Lobo-Gonzalez M, Ibanez B Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome Eur Heart J Acute Cardiovasc Care (2019) 8:443-56
Link to the full text in Repisalud
Rossello X, Gil V, Escoda R, Jacob J, Aguirre A, Martin-Sanchez FJ, Llorens P, Herrero Puente P, Rizzi M, Raposeiras-Roubin S, Wussler D, Muller CE, Gayat E, Mebazaa A, Miro O Impact of identifying precipitating factors on 30-day mortality in acute heart failure patients Eur Heart J Acute Cardiovasc Care (2019) 8:667-680
Jacob J, Llauger L, Herrero-Puente P, Martin-Sanchez FJ, Llorens P, Roset A, Gil V, Fuentes M, Lucas-Imbernon FJ, Miro O, ICASEMES-Research Group, Gil C, Alonso H, Perez-Llantada E, Llopis-Garcia G, Santos-Matallana MC, Barrenechea-Moxo MLD, Salgado-Perez L, Escoda R, Xipell C, Sanchez C, Gaytan JM, Perez-Dura MJ, Salvo E, Pavon J, Noval A, Torres JM, Lopez-Grima ML, Valero A, Juan MA, Aguirre A, Pedragosa MA, Minguez-Maso S, Alonso MI, Ruiz F, Franco JM, Mecina AB, Tost J, Berenguer M, Donea R, Sanchez-Ramon S, Carbajosa-Rodriguez V, Pinera P, Sanchez-Nicolas JA, Garate RT, Alquezar-Arbe A, Rizzi MA, Herrera S, Roset A, Cabello I, Haro A, Richard F, Alvarez-Perez JM, Lopez-Diez MP, Vazquez-Alvarez J, Prieto-Garcia B, Garcia MG, Gonzalez MS, Javaloyes P, Marquina V, Jimenez I, Hernandez N, Brouzet B, Espinosa B, Andueza JA, Romero R, Ruiz M, Calvache R, Serralta MTL, Jave LEC, Arriaga BA, Bergua BS, Mojarro EM, Jimenez BSA, Becquer LT, Burillo G, Garcia LL, LaSalle GC, Urbano CA, Soto ABG, Padial ED, Ferrer ES, Garrido JM, Lucas-Imbernon FJ, Gaya R, Bibiano C, Mir M, Rodriguez B, Carballo JL, Rodriguez-Adrada E, Miranda BR. Acute heart failure and adverse events associated with the presence of renal dysfunction and hyperkalaemia. EAHFE- renal dysfunction and hyperkalaemia. Eur J Intern Med (2019) 67:89-96

Pages